Patent US5116610A successfully refreshed from Google Patents.
US5116610A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Compositions for treating hypercholesterolemia
Assignee: Procter and Gamble Co
•
Filing: 1991-09-30
•
Granted: 1992-05-26
•
Expires: 2011-09-30
Abstract
Abstract Cholestyramine and polyol polyesters are administered orally to reduce blood cholesterol levels.
Inventors
- 👤 Charles D. Broaddus
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 19:15
CPC Classifications
A; A61; A61K; A61K36/00; A61K36/18; A61K36/185; A61K36/28; A61K36/286; A61K31/00; A61K31/74; A61K31/785; A61K36/13; A61K36/15; A61K36/31; A61K36/48; A61K36/63; A61K36/88; A61K36/889; A61K36/899
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
19 words
A composition of matter for reducing blood cholesterol levels, comprising: a) cholestyramine; and b) a nonabsorbable, nondigestible polyol polyester.
Claim 2
Dependent Claim
19 words
A composition of matter for reducing blood cholesterol levels, comprising: a) cholestyramine; and b) a nonabsorbable, nondigestible polyol polyester.
Claim 3
Dependent Claim
22 words
A composition according to claim 1 wherein the polyol polyester component (b) is sucrose octaoleate, sucrose octalinoleate, sucrose octapalmitate, and mixtures thereof.
Claim 4
Dependent Claim
18 words
A composition according to claim 2 wherein the weight ratio of component (a):component (b) is 3:1 to 1:3.
Claim 5
Dependent Claim
12 words
A composition according to claim 1 which is fortified with fat-soluble vitamins.
Claim 6
Independent Claim
42 words
A method for reducing blood cholesterol in a patient in need of such treatment, comprising orally administering to said patient a safe and effective amount of: a) cholestyramine; and b) a nonabsorbable, nondigestible polyol polyester; or c) mixtures of (a) and (b).
Claim 7
Independent Claim
42 words
A method for reducing blood cholesterol in a patient in need of such treatment, comprising orally administering to said patient a safe and effective amount of: a) cholestyramine; and b) a nonabsorbable, nondigestible polyol polyester; or c) mixtures of (a) and (b).
Claim 8
Dependent Claim
30 words
A method according to claim 5 which comprises oral ingestion of from 10 g to 40 g of component (a) and from 5 g to 50 g of component (b).
Claim 9
Dependent Claim
10 words
A method according to claim 6 which comprises chronic ingestion.
Claim 10
Dependent Claim
10 words
A method according to claim 7 which comprises daily ingestion.
Claim 11
Dependent Claim
47 words
A method according to claim 8 which comprises daily ingestion of from about 12 g to about 32 g of component (a) and from about 15 g to about 50 g of component (b), said ingestion being at two, three or four regularly-spaced intervals throughout the day.
Claim 12
Dependent Claim
20 words
A method according to claim 5 wherein the polyol polyester is sucrose octaoleate, sucrose octalinoleate, sucrose octapalmitate, and mixtures thereof.
Claim 13
Dependent Claim
17 words
A method according to claim 5 which includes the administration of fat-soluble vitamins in the treatment composition.
References Cited (Backward Citations)
US3499960A
Cited
US3600186A
Cited
US3579548A
Cited
US3923972A
Cited
US3974272A
Cited
US3954976A
Cited
US3963699A
Cited
US4034083A
Cited
US4005196A
Cited
US4005195A
Cited
US4241054A
Cited
US4264583A
Cited
US4382924A
Cited
US4368213A
Cited
US4461782A
Cited
US4517360A
Cited
US4518772A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-05-26 | 1995-11-25 | 1996-05-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-05-26 | 1999-11-25 | 2000-05-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-05-26 | 2003-11-25 | 2004-05-26 | $7700.00 | Window Closed / Lapsed |